SAR446959
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR446959, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee [Phase 1]